Product Name | NebuSelect™ Recombinant Biotinylated Human B7-H3 (4Ig) /B7-H3b, Avi-His-tag |
---|---|
Catalog Number | NBL-241049 |
Alias/Synonyms | B7-H3 (4Ig)/B7-H3b; B7-H3; CD276; PSEC0249;-4Ig-B7-H3; UNQ309; PRO352; B7 homolog 3; CD276 |
Appearance | see COA |
Molecule Weight | Gly27-Thr461 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q5ZPR3-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-241049-100ug | 100ug | Inquire | Inquire | |
NBL-241049-1mg | 1mg | Inquire | Inquire | |
NBL-241049-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human B7-H3 (4Ig) /B7-H3b, Avi-His-tag
Catalog#:
NBL-241049
Description:
NebuSelect™ Recombinant Biotinylated Human B7-H3 (4Ig) /B7-H3b, Avi-His-tag(Cat#NBL-241049) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly27-Thr461.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 49.5 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
Target Name:
B7-H3 (4Ig)/B7-H3b; B7-H3; CD276; PSEC0249;-4Ig-B7-H3; UNQ309; PRO352; B7 homolog 3; CD276
Target Information:
B7-H3, a member of the B7 family of immunomodulatory molecules, is overexpressed in a wide range of solid cancers.B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig‑B7‑H3 enhances T cell proliferation, T cell interferon-gamma (IFN-gamma) production, and cytotoxic T cells induction.
Amino Acid Sequence:
Gly27-Thr461
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.